Resolvin D1 Attenuates Inflammation and Pelvic Pain Associated with EAP by Inhibiting Oxidative Stress and NLRP3 Inflammasome Activation via the Nrf2/HO-1 Pathway-Reference-Cited by-同舟云学术

Resolvin D1 Attenuates Inflammation and Pelvic Pain Associated with EAP by Inhibiting Oxidative Stress and NLRP3 Inflammasome Activation via the Nrf2/HO-1 Pathway

Published:2023-08 Issue: Volume:Volume 16 Page:3365-3379
ISSN:1178-7031
Container-title:Journal of Inflammation Research
language:en
Short-container-title:JIR

Author:

Zhang Jiong,Chen Juan,Jiang Qing,Feng Rui,Zhao Xiaohu,Li Haolin,Yang Cheng,Hua Xiaoliang

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Reference50 articles.

1. HOW COMMON IS PROSTATITIS? A NATIONAL SURVEY OF PHYSICIAN VISITS

2. Nociceptive and inflammatory mediator upregulation in a mouse model of chronic prostatitis

3. Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline

4. Chronic Prostatitis and the Chronic Pelvic Pain Syndrome

5. Contemporary Management of Chronic Prostatitis/Chronic Pelvic Pain Syndrome

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The analgesic effects of Yu-Xue-Bi tablet (YXB) on mice with inflammatory pain by regulating LXA4-FPR2-TRPA1 pathway;Chinese Medicine;2024-08-06

2. Association of serum resolvin D1 with the risk of major adverse cardiovascular events in hemodialysis patients;International Urology and Nephrology;2024-07-19

3. 4‐Octyl itaconate alleviates experimental autoimmune prostatitis by inhibiting the NLRP3 inflammasome‐induced pyroptosis through activating Nrf2/HO‐1 pathway;The Prostate;2023-12-10

4. Long-term efficacy and safety of extracorporeal shock wave therapy (Li-ESWT) protocols in the treatment of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) patients;The Aging Male;2023-09-06